Síndrome DRESS asociado a fenitoína: informe de caso

Vallejos Narváez, Álvaro; Canal Forero, Julián Ernesto; Salazar Peña, David Felipe; Pérez López, Javier Alexander; Acelas González, Gabriel Esteban; Rojas Carvajal, David Alejandro; García Salazar, Javier Alejandro.
Rev. Hosp. Ital. B. Aires (2004) ; 41(1): 21-25, mar. 2021. ilus, tab
Artículo en Español | LILACS | ID: biblio-1178296

Documentos relacionados

  1. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial.
  2. Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial.
  3. Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial.
  4. Levetiracetam Versus Phenytoin or Fosphenytoin for Second-Line Treatment of Pediatric Status Epilepticus: A Meta-Analysis.
  5. The association of patient weight and dose of fosphenytoin, levetiracetam, and valproic acid with treatment success in status epilepticus.
  6. Efficacy and safety of phenytoin and levetiracetam for acute symptomatic seizures in children with acute encephalitis syndrome: an open label, randomised controlled trial.
  7. Why we prefer levetiracetam over phenytoin for treatment of status epilepticus.
  8. Decreased Systemic Busulfan Exposure After Oral Dosing With Concomitant Levetiracetam Compared With Phenytoin.
  9. Development and Use of an Ex-Vivo In-Vivo Correlation to Predict Antiepileptic Drug Clearance in Patients Undergoing Continuous Renal Replacement Therapy.
  10. Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus.